| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.06 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.06 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.07 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.07 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | 0.83 | 0.07 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.07 |